Related Experiment Video

Updated: Mar 10, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

MicroRNA-based screens for synthetic lethal interactions with c-Myc

Youjun Li1, Yahui Zhu2, Edward V Prochownik3

  • 1College of Life Sciences, Wuhan University, Wuhan 430072, China; Medical Research Institute, Wuhan University, Wuhan 430071, China.

RNA & Disease (Houston, Tex.)
|December 16, 2016
PubMed

Insights

MicroRNAs (miRs) are key regulators in cancer. This review explores miRs targeted by c-Myc (Myc), highlighting their roles in cancer development and potential as therapeutic targets for Myc-driven cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRs) are small, non-coding RNAs involved in cancer development and progression.
  • Their stability and ease of synthesis suggest potential as cancer therapeutics.
  • c-Myc (Myc) is a frequently deregulated oncogenic transcription factor critical in cancer pathogenesis.

Purpose of the Study:

  • To review miRs regulated by Myc, acting as both positive and negative targets.
  • To discuss the role of these miRs in Myc-driven cancer phenotypes.
  • To explore recent findings on Myc-miR synthetic lethal interactions and therapeutic opportunities.

Main Methods:

  • Literature review of studies investigating microRNA regulation by c-Myc.
  • Analysis of identified positive and negative Myc target miRs.
  • Examination of synthetic lethal interactions between Myc and miRs.

Main Results:

  • Identification of specific miRs directly and indirectly regulated by Myc.
  • Elucidation of how these miRs contribute to complex cellular phenotypes in Myc-driven cancers.
  • Emerging evidence of synthetic lethal interactions between Myc and miRs.

Conclusions:

  • MicroRNAs play a complex and significant role in Myc-mediated biological functions.
  • Understanding Myc-miR interactions is crucial for developing novel therapeutic strategies.
  • Targeting miRs offers promising avenues for treating Myc-driven human cancers.
Keywords:
c-MyccancermicroRNAssynthetic lethality

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.7K

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.8K